This content was recorded from the live event on November 4, 2020. If you attended and claimed credit, please do not complete this release. 

Faculty

Needs Statement

On July 15th, 2020, House Bill 135 took effect in the state of Kentucky. This allows prescriptive authority for Physicians Assistants for Schedule III through V controlled substances provided that certain criteria are met. One of these criteria is that a PA must have 7.5 hours of CME related to controlled substance diversion, pain management, addiction disorders, use of the electronic system for monitoring controlled substances or any combination of two ore more of these subjections prior to apply for approval and then every 2 years thereafter.

Target Audience

Physicians, PA's, Pharmacists

Objectives

Upon completition of this activity, participants will be able to:
1. Discuss principles of opioid stewardship and pain management
2. Describe how to navigate the electronic system for monitoring controlled substances in Kentucky (KASPER)
3. Review the prescriptive authority and responsibility of physician assistants when writing for controlled substance

Accreditation

In support of improving patient care, this activity has been planned and implemented by University of Kentucky HealthCare CECentral and Epraim McDowell Regional Medical Center. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA credit:
This enduring activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ACGME Competencies - Patient Care, Medical Knowledge, Practice-based Learning and Improvement

ACPE credit: 

This knowledge-based activity will award 0.75 contact hour (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. 

This training has been approved by the KBML as meeting the statutory requirements of HB1. KBML ID#0920-H1.0-UK21b 

 

Faculty Disclosure

No speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

This activity is collaborated with Ephraim McDowell Regional Medical Center.